International Business

Genentech has named Alexander Hardy its CEO effective March 1, succeeding Bill Anderson.

Brian Rice will join Cardinal Health as executive vice president, chief information officer and customer support services, effective Feb. 4.

Todd Branning, formerly Teva’s CFO, has joined Amneal as senior vice president and CFO.

Samsung Bioepis has received its first approval for an oncology drug from the Food and Drug Administration, which has given the green light to the company's Ontruzant — a biosimilar of Herceptin.

Yellow Wood Partners announced that Patrick O’Brien would become vice-chairman of Paris Presents, and Bill George will be taking over as its CEO.

Quest Products, a Promus Equity Partners portfolio company, is merging with OraHealth, maker of XyliMelts for Dry Mouth.

The organization announced that David Campbell, vice president of North America regulatory affairs and policy at RB Health, has been elected chair of the board of directors.

A former Revlon executive has joined Coty as COO of consumer beauty, and a new CFO and chief global supply chain officer also have been appointed.